Large scale multiple sclerosis registry launches.
| CONTEXT: Announcement of The OM1 MS registry is a continually updating database of more than 20,000 patientsprospectively followed with deep clinical, laboratory and other data, such as longitudinal outcomes, Expanded Disability Status Scale (EDSS) scores, relapses, subtypes, and treatment response. Additionally, researchers can tap into data from another 460,000 MS patients in the OM1 Real-World Data Cloud™, which can be used for modelling, analytics, and other research purposes. READ TIME: 1 min  1. “The OM1 MS registry is a continually updating database of more than 20,000 patientsprospectively followed with deep clinical, laboratory and other data, such as longitudinal outcomes, Expanded Disability Status Scale (EDSS) scores, relapses, subtypes, and treatment response.” 2. “BOSTON, July 14, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its multiple sclerosis (MS) registry.” 3. “Registry provides access to MS patients longitudinal outcomes, EDSS scores, relapses, subtypes, and treatment response.” 4. “”The high availability and depth of the registry data enables healthcare stakeholders to answer important questions around natural history, disease progression, treatment response and outcomes,” said Dr. Richard Gliklich, CEO of OM1.” 5. “For more information, Hurley. Head of Marketing, OM1. With a focus on chronic conditions, OM1 is a real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes.” Source URL: https://markets.businessinsider.com/news/stocks/om1-launches-multiple-sclerosis-registry-with-more-than-20-000-patients-prospectively-followed-with-deep-clinical-data-1030607124 |